Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 109, Issue 3, 2014, Pages 173-174

  Alexander, Neal D E ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Elimination; Lymphatic filariasis; Mass drug administration

Indexed keywords

ANTINEMATODAL AGENT; ANTIFILARIAL AGENT; DIETHYLCARBAMAZINE;

AGE; ANTIMICROBIAL THERAPY; ARTICLE; CRITICAL ILLNESS; DRACUNCULIASIS; DRACUNCULUS; DRUG SAFETY; HEALTH CARE UTILIZATION; HUMAN; INDIA; INFECTION CONTROL; INSECT BITE; LYMPHATIC FILARIASIS; MASS DRUG ADMINISTRATION; MOSQUITO; PARASITE CLEARANCE; PREGNANCY; PROGRAM EFFECTIVENESS; PUBLIC HEALTH SERVICE; RURAL AREA; TREATMENT DURATION; URBAN AREA; DISEASE ERADICATION; ELEPHANTIASIS, FILARIAL; HEALTH CARE PLANNING; ORGANIZATION AND MANAGEMENT;

DIETHYLCARBAMAZINE; DISEASE ERADICATION; ELEPHANTIASIS, FILARIAL; FILARICIDES; HEALTH PLAN IMPLEMENTATION; HUMANS;

EID: 84928881758     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/tru204     Document Type: Article

References (11)

1. WHO. Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis. Geneva: World Health Organization; 2010.
2. Stolk WA, Swaminathan S, van Oortmarssen GJ et al. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study 2003;188:1371-81.
3. WHO. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement 2012;87:478-82.
4. WHO. Global programme to eliminate lymphatic filariasis: progress report, 2013. Global programme to eliminate lymphatic filariasis: progress report, 2013 2014;89:409-18.
5. Babu BV, Babu GR. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review 2014;108:538-49.
6. National Vector Borne Disease Control Programme. Mass Drug Administration: Government of India; 2014. http://nvbdcp.gov.in/ mda.html [accessed 23 October 2014].
7. WHO. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. Geneva:World Health Organization; 2011.
8. Krentel A, Fischer PU, Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis 2013;7:e2447.
9. Al-Awadi AR, Al-Kuhlani A, Breman JG et al. Guinea worm (Dracunculiasis) eradication: update on progress and endgame challenges. Guinea worm (Dracunculiasis) eradication: update on progress and endgame challenges 2014;108:249-51.
10. Richards FO, Eigege A, Miri ES et al. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria. PLoS Negl Trop Dis 2011;5:e1346.
11. Swaminathan S, Perumal V, Adinarayanan S et al. Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation. Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation 2012;6:e1926.